한글목차

일본의 약물전달 시장의 시장 규모는 2024년에 127억 달러에 달했습니다. 향후 IMARC Group은 시장이 2033년까지 181억 달러에 달하며, 2025-2033년의 성장률(CAGR)은 4%에 달할 것으로 예측하고 있습니다. 이러한 디바이스 시장은 만성질환의 유병률 상승, 제약 연구의 진보, 신규 약물전달 기술의 지속적 개발에 의해 촉진되고 있습니다.

본 리포트에서 답변하는 주요 질문

• 일본의 약물전달 시장은 지금까지 어떻게 추이해 왔으며, 향후 어떻게 추이하는가?
• COVID-19가 일본의 약물전달 시장에 미친 영향은?
• 일본의 약물전달 시장의 투여 경로별 내역은?
• 일본의 약물전달 시장의 용도별 내역은?
• 일본의 약물전달 시장의 최종사용자별 내역은?
• 일본의 약물전달 시장의 밸류체인에는 어떤 단계가 있는가?
• 일본의 약물전달 디바이스의 주요 촉진요인과 과제는?
• 일본의 약물전달 시장의 구조와 주요 기업은?
• 일본의 약물전달 시장에서 경쟁의 정도는?

목차

제1장 서문

제2장 조사 범위와 조사 방법

• 조사의 목적
• 이해관계자
• 데이터 소스
• 시장 추정
• 조사 방법

제3장 개요

제4장 일본의 약물전달 시장 : 서론

• 개요
• 시장 역학
• 업계 동향
• 경쟁 정보

제5장 일본의 약물전달 시장 구도

• 과거 및 현재 시장 동향(2019-2024년)
• 시장 예측(2025-2033)

제6장 일본의 약물전달 시장 : 투여 경로별 내역

• 주사
• 외용
• 안과
• 기타

제7장 일본의 약물전달 시장 : 용도별 내역

• 암
• 심장혈관
• 당뇨병
• 감염증
• 기타

제8장 일본의 약물전달 시장 : 최종사용자별 내역

• 병원
• 외래 수술 센터
• 기타

제9장 일본의 약물전달 시장 : 경쟁 구도

• 개요
• 시장 구조
• 시장 기업 포지셔닝
• 주요 성공 전략
• 경쟁 대시보드
• 기업 평가 상한

제10장 주요 기업의 개요

제11장 일본의 약물전달 시장 : 업계 분석

• 촉진요인·억제요인·기회
• Porter's Five Forces 분석
• 밸류체인 분석

제12장 부록

영문목차

Japan drug delivery devices market size reached USD 12.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 18.1 Billion by 2033, exhibiting a growth rate (CAGR) of 4% during 2025-2033. The market for these devices is driven by the rising prevalence of chronic diseases, advancements in pharmaceutical research, and the continual development of novel drug delivery technologies.

Drug delivery devices constitute a fundamental component of medical equipment designed to administer medications and therapeutic agents across diverse routes in the human body. They are specifically to ensure precise, controlled, and targeted delivery of drugs to achieve optimal therapeutic effect while minimizing side effects. They encompass a variety of forms including, but not limited to, injectors, inhalers, patches, and implantable devices. The evolution of drug delivery devices is crucial in addressing the growing need for innovative solutions to administer medication effectively to treat various diseases and conditions. They also play a pivotal role in transforming therapeutic practices, thereby contributing significantly to the advancement of healthcare solutions.

Japan Drug Delivery Devices Market Trends:

The Japan drug delivery devices market is traversing a phase of substantial growth and transformation, propelled by several pivotal drivers and marked by emerging trends. A primary driver is the escalating prevalence of chronic diseases and aging population in Japan, necessitating advanced therapeutic approaches and effective drug delivery systems. These health conditions demand enhanced medical attention and innovative therapeutic solutions, paving the way for the proliferation of sophisticated drug delivery devices in the country. Japan's strong focus on research and development is another significant catalyst, fostering innovations and advancements in drug delivery technologies. The emphasis on developing patient-centric devices that are more convenient, efficient, and less invasive is driving the trend of personalization and customization in the market. Technological advancements are leading to the emergence of novel drug delivery systems, aiming to optimize therapeutic outcomes and mitigate adverse effects. Moreover, a supportive regulatory environment and substantial investments in healthcare are facilitating the rapid adoption of new technologies and ensuring the safety and efficacy of these devices. The increasing consumer awareness and healthcare literacy are also contributing to the growing demand for advanced drug delivery devices. The convergence of nanotechnology with drug delivery represents a noteworthy trend, offering opportunities for creating devices with enhanced precision and control. In essence, the amalgamation of innovative technologies, burgeoning healthcare needs, and a conducive regulatory landscape is shaping the trajectory of the drug delivery devices market in Japan, highlighting a promising outlook filled with innovations and opportunities.

Japan Drug Delivery Devices Market Segmentation:

Route of Administration Insights:

• Injectable
• Topical
• Ocular
• Others

Application Insights:

• Cancer
• Cardiovascular
• Diabetes
• Infectious diseases
• Others

End User Insights:

• Hospitals
• Ambulatory Surgical Centers
• Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

• How has the Japan drug delivery devices market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan drug delivery devices market?
• What is the breakup of the Japan drug delivery devices market on the basis of route of administration?
• What is the breakup of the Japan drug delivery devices market on the basis of application?
• What is the breakup of the Japan drug delivery devices market on the basis of end user?
• What are the various stages in the value chain of the Japan drug delivery devices market?
• What are the key driving factors and challenges in the Japan drug delivery devices?
• What is the structure of the Japan drug delivery devices market and who are the key players?
• What is the degree of competition in the Japan drug delivery devices market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Drug Delivery Devices Market - Introduction

• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence

5 Japan Drug Delivery Devices Market Landscape

• 5.1 Historical and Current Market Trends (2019-2024)
• 5.2 Market Forecast (2025-2033)

6 Japan Drug Delivery Devices Market - Breakup by Route of Administration

• 6.1 Injectable
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends (2019-2024)
  • 6.1.3 Market Forecast (2025-2033)
• 6.2 Topical
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends (2019-2024)
  • 6.2.3 Market Forecast (2025-2033)
• 6.3 Ocular
  • 6.3.1 Overview
  • 6.3.2 Historical and Current Market Trends (2019-2024)
  • 6.3.3 Market Forecast (2025-2033)
• 6.4 Others
  • 6.4.1 Historical and Current Market Trends (2019-2024)
  • 6.4.2 Market Forecast (2025-2033)

7 Japan Drug Delivery Devices Market - Breakup by Application

• 7.1 Cancer
  • 7.1.1 Overview
  • 7.1.2 Historical and Current Market Trends (2019-2024)
  • 7.1.3 Market Forecast (2025-2033)
• 7.2 Cardiovascular
  • 7.2.1 Overview
  • 7.2.2 Historical and Current Market Trends (2019-2024)
  • 7.2.3 Market Forecast (2025-2033)
• 7.3 Diabetes
  • 7.3.1 Overview
  • 7.3.2 Historical and Current Market Trends (2019-2024)
  • 7.3.3 Market Forecast (2025-2033)
• 7.4 Infectious Diseases
  • 7.4.1 Overview
  • 7.4.2 Historical and Current Market Trends (2019-2024)
  • 7.4.3 Market Forecast (2025-2033)
• 7.5 Others
  • 7.5.1 Historical and Current Market Trends (2019-2024)
  • 7.5.2 Market Forecast (2025-2033)

8 Japan Drug Delivery Devices Market - Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Overview
  • 8.1.2 Historical and Current Market Trends (2019-2024)
  • 8.1.3 Market Forecast (2025-2033)
• 8.2 Ambulatory Surgical Centers
  • 8.2.1 Overview
  • 8.2.2 Historical and Current Market Trends (2019-2024)
  • 8.2.3 Market Forecast (2025-2033)
• 8.3 Others
  • 8.3.1 Historical and Current Market Trends (2019-2024)
  • 8.3.2 Market Forecast (2025-2033)

9 Japan Drug Delivery Devices Market - Competitive Landscape

• 9.1 Overview
• 9.2 Market Structure
• 9.3 Market Player Positioning
• 9.4 Top Winning Strategies
• 9.5 Competitive Dashboard
• 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

• 10.1 Company A
  • 10.1.1 Business Overview
  • 10.1.2 Product Portfolio
  • 10.1.3 Business Strategies
  • 10.1.4 SWOT Analysis
  • 10.1.5 Major News and Events
• 10.2 Company B
  • 10.2.1 Business Overview
  • 10.2.2 Product Portfolio
  • 10.2.3 Business Strategies
  • 10.2.4 SWOT Analysis
  • 10.2.5 Major News and Events
• 10.3 Company C
  • 10.3.1 Business Overview
  • 10.3.2 Product Portfolio
  • 10.3.3 Business Strategies
  • 10.3.4 SWOT Analysis
  • 10.3.5 Major News and Events
• 10.4 Company D
  • 10.4.1 Business Overview
  • 10.4.2 Product Portfolio
  • 10.4.3 Business Strategies
  • 10.4.4 SWOT Analysis
  • 10.4.5 Major News and Events
• 10.5 Company E
  • 10.5.1 Business Overview
  • 10.5.2 Product Portfolio
  • 10.5.3 Business Strategies
  • 10.5.4 SWOT Analysis
  • 10.5.5 Major News and Events

11 Japan Drug Delivery Devices Market - Industry Analysis

• 11.1 Drivers, Restraints, and Opportunities
  • 11.1.1 Overview
  • 11.1.2 Drivers
  • 11.1.3 Restraints
  • 11.1.4 Opportunities
• 11.2 Porters Five Forces Analysis
  • 11.2.1 Overview
  • 11.2.2 Bargaining Power of Buyers
  • 11.2.3 Bargaining Power of Suppliers
  • 11.2.4 Degree of Competition
  • 11.2.5 Threat of New Entrants
  • 11.2.6 Threat of Substitutes
• 11.3 Value Chain Analysis

12 Appendix